GW Pharma hits high as cannabis drug helps fight epilepsy

[OZ Stoners]

By Ben Hirschler LONDON (Reuters) - An experimental cannabis drug has produced promising results in a small study of children with hard-to-treat epilepsy, sending shares in its British maker GW Pharmaceuticals to an all-time high. It already sells Sativex for spasticity caused by multiple sclerosis across Europe. The latest findings for its new product Epidiolex follow an assessment of 27 ...

 

View the full article

[ZEN2U]

This should be sent to every State and Federal member. Both my members will be receiving an email with the info.

 

Not that I agree with big pharma controling canna, but pollies can only bury their heads in the sand to the evidence of benifits from med canna for so long. They have to come up for a breath eventually.

 

Don't let them ignore the evidence, become pro-active.

Edited June 18, 2014 by ZEN2U

[Faith]

heya Zen2U   I think they are stalling mainly...until they can work out a way to control the whole show.  from outlet to backyarders and closet growers.  they don't want to be SEEN as un-democratic, and they don't know how to serve their masters without doing so....oh, and they ain't that clever so it is taking awhil the silly blighters